UBS OCONNOR LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$992,338
-49.8%
110,752
-37.0%
0.02%
-59.7%
Q2 2023$1,977,210
-2.8%
175,752
-0.5%
0.06%0.0%
Q1 2023$2,034,444
-99.9%
176,601
+0.1%
0.06%
+44.2%
Q3 2022$2,241,000,000
+43.5%
176,490
-22.4%
0.04%
+87.0%
Q2 2022$1,562,000,000227,3580.02%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,220,034$19,891,50530.79%
MPM ASSET MANAGEMENT LLC 4,951,303$44,363,67523.76%
Atlas Venture Life Science Advisors, LLC 9,885,449$88,573,62313.72%
Logos Global Management LP 2,180,000$19,532,8002.61%
TCG Crossover Management, LLC 1,650,150$14,785,3442.18%
VR Adviser, LLC 2,173,913$19,478,2602.05%
Altium Capital Management LP 315,000$2,822,4001.47%
Vivo Capital, LLC 1,035,136$9,274,8191.02%
Octagon Capital Advisors LP 692,945$6,208,7870.95%
ACUTA CAPITAL PARTNERS, LLC 146,500$1,312,6400.88%
View complete list of DYNE THERAPEUTICS INC shareholders